KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) Equity Ratio (2009 - 2026)

West Pharmaceutical Services recorded quarterly Equity Ratio of 0.73 in Q1 2026, down 2.17% quarter-over-quarter from 0.74 in Q4 2025, and down 1.88% year-over-year from 0.74 in Q1 2025.

West Pharmaceutical Services' Equity Ratio history runs 18 years deep, the most recent figure standing at 0.73 for Q1 2026.

  • In Q1 2026, Equity Ratio fell 1.88% year-over-year to 0.73; the TTM figure through Mar 2026 stood at 0.73 (down 1.88% YoY), while the FY2025 annual figure was 0.74, up 1.03% from the prior year.
  • Equity Ratio came in at 0.73 for Q1 2026 at West Pharmaceutical Services, down from 0.74 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.76 in Q3 2023 to a low of 0.71 in Q1 2022.
  • A 5-year average of 0.74 and a median of 0.74 in 2025 frame the typical range for Equity Ratio.
  • Across the five-year window, Equity Ratio increased 6.3% in 2022 and fell 2.14% in 2024, its largest moves.
  • West Pharmaceutical Services' Equity Ratio stood at 0.74 in 2022, then gained by 1.34% to 0.75 in 2023, then fell by 2.14% to 0.74 in 2024, then increased by 1.03% to 0.74 in 2025, then retreated by 2.17% to 0.73 in 2026.
  • According to Business Quant data, Equity Ratio over the past three periods registered 0.73, 0.74, and 0.74 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 0.88
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 0.47
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 0.74
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 0.73
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 0.35
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 0.67
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 0.66
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 0.30
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 0.52
10 Repligen 6.39 Bn 5.41 Bn 108.28 Mn 0.72

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.73
Dec 31, 2025 0.74
Sep 30, 2025 0.74
Jun 30, 2025 0.74
Mar 31, 2025 0.74
Dec 31, 2024 0.74
Sep 30, 2024 0.75
Jun 30, 2024 0.74
Mar 31, 2024 0.74
Dec 31, 2023 0.75
Sep 30, 2023 0.76
Jun 30, 2023 0.75
Mar 31, 2023 0.75
Dec 31, 2022 0.74
Sep 30, 2022 0.74
Jun 30, 2022 0.72
Mar 31, 2022 0.71
Dec 31, 2021 0.70
Sep 30, 2021 0.70
Jun 30, 2021 0.69
Mar 31, 2021 0.67
Dec 31, 2020 0.66
Sep 30, 2020 0.67
Jun 30, 2020 0.67
Mar 31, 2020 0.66
Dec 31, 2019 0.67
Sep 30, 2019 0.68
Jun 30, 2019 0.68
Mar 31, 2019 0.67
Dec 31, 2018 0.71
Sep 30, 2018 0.69
Jun 30, 2018 0.68
Mar 31, 2018 0.70
Dec 31, 2017 0.69
Sep 30, 2017 0.68
Jun 30, 2017 0.67
Mar 31, 2017 0.67
Dec 31, 2016 0.65
Sep 30, 2016 0.66
Jun 30, 2016 0.65
Mar 31, 2016 0.64
Dec 31, 2015 0.60
Sep 30, 2015 0.60
Jun 30, 2015 0.59
Mar 31, 2015 0.59
Dec 31, 2014 0.57
Sep 30, 2014 0.58
Jun 30, 2014 0.57
Mar 31, 2014 0.55
Dec 31, 2013 0.54
Sep 30, 2013 0.50
Jun 30, 2013 0.49
Mar 31, 2013 0.47
Dec 31, 2012 0.47
Sep 30, 2012 0.47
Jun 30, 2012 0.46
Dec 31, 2011 0.47
Sep 30, 2011 0.49
Jun 30, 2011 0.49
Mar 31, 2011 0.49
Dec 31, 2010 0.48
Sep 30, 2010 0.49
Jun 30, 2010 0.52
Dec 31, 2009 0.46